| 查看: 7687 | 回復(fù): 10 | ||||||||||||||
[調(diào)劑信息]
廣東醫(yī)學(xué)院梁欣課題組接收調(diào)劑研究生
|
| 學(xué)校: | 廣東醫(yī)學(xué)院 |
| 專業(yè): | 理學(xué)->基礎(chǔ)醫(yī)學(xué)->病理學(xué)與病理生理學(xué) |
| 年級(jí): | 2023 |
| 招生人數(shù): | 1 |
| 招生狀態(tài): | 正在招生中 |
| 聯(lián)系方式: | ********* (為保護(hù)個(gè)人隱私,聯(lián)系方式僅限APP查看) |
|
梁欣,女,山東日照人,博士,碩士研究生導(dǎo)師,現(xiàn)在廣東醫(yī)科大學(xué)生理教研室任教。先后就讀于西華大學(xué),西北大學(xué),中國(guó)科學(xué)院大學(xué)獲得學(xué)士,碩士和博士學(xué)位,在美國(guó)圣路易斯大學(xué),清華大學(xué)深圳研究生院,中山大學(xué)進(jìn)行研究工作。發(fā)表sci研究論文20余篇,以通訊作者和第一作者在nano today,acs nano, journal of controlled release, nanoscale, nano research ,journal of biological chemistry(2篇)和theranostics等國(guó)際著名學(xué)術(shù)期刊發(fā)表sci論文13篇,他引400余次,單篇論文最高引用270余次。2篇esi高被引論文。獲授權(quán)發(fā)明專利3項(xiàng)。獲2020年華夏醫(yī)學(xué)科技獎(jiǎng)三等獎(jiǎng),深圳市海外高層次人才,深圳市光明區(qū)緊缺人才。主要研究方向:藥物遞送,腫瘤免疫治療,自身免疫性疾。t斑狼瘡)的治療。 近5年發(fā)表的部分論文: x. liang#, l. janks#, tm egan. (2022). using whole-cell electrophysiology and patch-clamp photometry to characterize p2x7 receptor currents. in: nicke, a. (eds) the p2x7 receptor. methods in molecular biology, vol 2510:217-237. humana, new york, ny.外文參編圖書 f. meng, l. li, z. zhang, z. lin, j. zhang, x. liang#, x. zhang#. biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity. journal of extracellular vesicles. 11(12):e12289. (if=17.337, 中科院醫(yī)學(xué)2區(qū)) zhangyan jing*, yuan li*, yumeng ma*, xiaozhou zhang, xin liang#, xudong zhang# leverage biomaterials to modulate immunity for type 1 diabetes. frontiers in immunology. 2022, 13:997287. (if=8.786, 醫(yī)學(xué)2區(qū)) liyan li*, qianwei miao*, fanqiang meng*, baoqi li, tianyuan xue, tianliang fang, zhirang zhang, jinxie zhang, xinyu ye, yang kang, xingding zhang, qian chen, xin liang#, hongbo chen#, xudong zhang#. genetic engineering cellular vesicles expressing cd64 as checkpoint antibody carrier for cancer immunotherapy. theranostics. 2021, 11(12), 6033-6043. (if = 11.6,醫(yī)學(xué)1區(qū)) b. li#,t. fang#, y. li#, z. zhang, l. li, f. meng, j. wang, l. hou, x. liang*, x. zhang*, z. gu*. engineered t cell extracellular vesicles displaying pd-1 boost anti-tumor immunity. nano today. 46, 2022, 101606. (if = 18.962, 中科院化學(xué)綜合1區(qū)) t. xue#, z. zhang#, t. fang#, b. li, y. li, l. li, y. jiang, f. duan, f. meng*, x. liang*, x. zhang*. cellular vesicles expressing pd-1-blocking scfv reinvigorate t cell immunity against cancer. nano research. 2022, 15(6): 5295-5304. (if = 10.269,中科院材料科學(xué)1區(qū)) x. ye#, x. liang#, et al. surgical tumor-derived personalized photothermal vaccine formulation for cancer immunotherapy, acs nano, 2019, 13(3), 2956-2968. (if = 15.9, 中科院材料科學(xué)1區(qū),esi高被引) xudong zhang*, xin liang*, jianjun gu, danfeng chang, jinxie zhang, zhaowei chen, yangqi ye, chao wang, wei tao, xiaowei zeng, gan liu, yongjun zhang, lin mei#,zhen gu#. investigation and intervention of autophagy to guide cancer treatment with nanogels. nanoscale. 20170107, 9(1):150-163. (if = 7.79, jcr一區(qū),esi高被引,26) xinliang*, yin yang*, lijun wang*, xianbing zhu, xiaowei zeng, xiaojin wu, xudong zhang#, mei lin#. ph-triggered burst intracellular release from hollow microspheres to induce autophagic cancer cell death. journal of materials chemistry b. 20151208, 3(48): 9383-9396. (if = 6.3, jcr一區(qū),8) xin liang, samways, ds., wolf, k., bowles, ea., richards, jp., bruno, j., dutertre, s., dipaolo rj., egan tm, quantifying ca2+ current and permeability in atp-gated p2x7 receptors. journal of biological chemistry,20150320, 290(12): 7930-7942. (if = 5.2, jcr二區(qū),24) x. liang#, x. ye#, et al. photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation, j. controlled release, 2019, 296, 150~161. (if = 9.8, 中科院醫(yī)學(xué)1區(qū), esi高被引,2020年esi前0.1%熱點(diǎn)論文) x. liang, samways, ds., et al., ca2+ flux through splice variants of the atp-gated ionotropic receptor p2x7 is regulated by its cytoplasmic n terminus. j. biological chemistry, 2019, 294(33), 12521-12533. (if = 5.2, 中科院生物學(xué)2區(qū)) 科研經(jīng)費(fèi)充足,優(yōu)先招收有生物背景的同學(xué),例如本科為:生物技術(shù),生物工程等同學(xué),有意愿同學(xué)請(qǐng)發(fā)送簡(jiǎn)歷至:2176872651@qq.com 發(fā)自小木蟲Android客戶端 |
新蟲 (小有名氣)
新蟲 (小有名氣)
新蟲 (小有名氣)
新蟲 (初入文壇)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 341求調(diào)劑(一志愿湖南大學(xué)070300) +5 | 番茄頭--- 2026-03-22 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 085600材料與化工調(diào)劑 +7 | A-哆啦Z夢(mèng) 2026-03-23 | 12/600 |
|
|
[考研] 291 求調(diào)劑 +4 | 化工2026屆畢業(yè)?/a> 2026-03-21 | 5/250 |
|
|
[考研] 求調(diào)劑一志愿海大,0703化學(xué)學(xué)碩304分,有大創(chuàng)項(xiàng)目,四級(jí)已過 +6 | 幸運(yùn)哩哩 2026-03-22 | 10/500 |
|
|
[考研] 生物學(xué)071000 329分求調(diào)劑 +5 | 我愛生物生物愛?/a> 2026-03-17 | 5/250 |
|
|
[考研] 319求調(diào)劑 +4 | 小力氣珂珂 2026-03-20 | 4/200 |
|
|
[考研] 354求調(diào)劑 +7 | Tyoumou 2026-03-18 | 10/500 |
|
|
[考研] 廣西大學(xué)材料導(dǎo)師推薦 +3 | 夏夏夏小正 2026-03-17 | 5/250 |
|
|
[考研] 一志愿深大,0703化學(xué),總分302,求調(diào)劑 +4 | 七月-七七 2026-03-21 | 4/200 |
|
|
[考研] 268求調(diào)劑 +9 | 簡(jiǎn)單點(diǎn)0 2026-03-17 | 9/450 |
|
|
[考研] 279求調(diào)劑 +5 | 紅衣隱官 2026-03-21 | 5/250 |
|
|
[考研] 22 350 本科985求調(diào)劑,求老登收留 +3 | 李軼男003 2026-03-20 | 3/150 |
|
|
[考研] 初始318分求調(diào)劑(有工作經(jīng)驗(yàn)) +3 | 1911236844 2026-03-17 | 3/150 |
|
|
[考研] 304求調(diào)劑 +6 | 曼殊2266 2026-03-18 | 6/300 |
|
|
[考研] 304求調(diào)劑 +7 | 司空. 2026-03-18 | 7/350 |
|
|
[考研] 353求調(diào)劑 +3 | 拉鉤不許變 2026-03-20 | 3/150 |
|
|
[考研] 招收調(diào)劑碩士 +4 | lidianxing 2026-03-19 | 12/600 |
|
|
[考研]
|
不想起名字112 2026-03-19 | 3/150 |
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | 18889395102 2026-03-18 | 4/200 |
|
|
[考博] 26博士申請(qǐng) +3 | 1042136743 2026-03-17 | 3/150 |
|